Valeo Financial Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-513
| Closed | -$16K | – | 1236 |
|
|
2021
Q1 | $16K | Hold |
513
| – | – | ﹤0.01% | 1163 |
|
|
2020
Q4 | $10K | Buy |
513
+175
| +52% | +$3.41K | ﹤0.01% | 1177 |
|
|
2020
Q3 | $4K | Hold |
338
| – | – | ﹤0.01% | 1257 |
|
|
2020
Q2 | $4K | Hold |
338
| – | – | ﹤0.01% | 1519 |
|
|
2020
Q1 | $5K | Hold |
338
| – | – | ﹤0.01% | 1259 |
|
|
2019
Q4 | $9K | Hold |
338
| – | – | ﹤0.01% | 1128 |
|
|
2019
Q3 | $10K | Hold |
338
| – | – | ﹤0.01% | 1014 |
|
|
2019
Q2 | $9K | Buy |
338
+146
| +76% | +$3.89K | ﹤0.01% | 1052 |
|
|
2019
Q1 | $6K | Sell |
192
-160
| -45% | -$5K | ﹤0.01% | 1098 |
|
|
2018
Q4 | $10K | Buy |
352
+109
| +45% | +$3.1K | ﹤0.01% | 878 |
|
|
2018
Q3 | $11K | Buy |
243
+83
| +52% | +$3.76K | ﹤0.01% | 933 |
|
|
2018
Q2 | $7K | Buy |
+160
| New | +$7K | ﹤0.01% | 1038 |
|